リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh

Nagata, Abir 大阪大学

2021.11.04

概要

Atopic dermatitis (AD) is the foremost non-fatal skin-related disease that affects all age groups. Despite the growing prevalence of AD in low-and middle-income countries, its physiological conse-quences remain overlooked in countries like Bangladesh. Therefore, we aim to assess and characterize the influence of AD on the health-related quality of life (HRQoL) in Bangladeshi patients. A cross-sectional study comprising 184 eligible adults (83 men and 101 women; mean age, 33.46 ± 15.44 years) was conducted at the dermatology outpatient department of Shaheed Suhrawardy Medical College Hospital (a tertiary hospital in Dhaka, Bangladesh). AD was determined using the UK Working Party criteria. A structured questionnaire, Eczema Area and Severity Index (EASI), and Dermatology Life Quality Index (DLQI) were administered to obtain information on patient characteristics, AD severity, and HRQoL. The mean DLQI score for the entire sample was 11.29 ± 5.27 (range, 1–26), and 51.60% reported the disease greatly affected their lives. Bivariate analysis revealed significant differences in self-rated health measures of DLQI scores in terms of self-reported AD severity, overall health, and the EASI. In multivariable regression models adjusted for patient characteristics, the self-perceived severe AD group reported significantly higher DLQI scores (coefficient = 2.72; 95% confidence interval (CI) = 0.38–5.05; p = 0.022) than the mild group. Concurrently, we observed a substantial increase in the DLQI scores among patients with moderate and severe EASI scores (coefficient = 1.96, 95% CI = 0.08–3.92, p < 0.05 and coefficient = 4.35, 95% CI = 1.98–6.72, p < 0.001, respectively) than in those with mild EASI scores, suggesting that HRQoL was markedly influenced by greater AD severity. These findings highlight the need for a more patient-centric approach to the management of AD in order to alleviate patient suffering and, thereby, improve HRQoL.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Langan, S.M.; Irvine, A.D.; Weidinger, S. Atopic dermatitis. Lancet 2020, 396, 345–360. [CrossRef]

2. Luger, T.; Amagai, M.; Dreno, B.; Dagnelie, M.A.; Liao, W.; Kabashima, K.; Schikowski, T.; Proksch, E.; Elias, P.M.; Simon, M.; et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J. Dermatol. Sci. 2021, 102, 142–157. [CrossRef] [PubMed]

3. Lee, H.H.; Patel, K.R.; Singam, V.; Rastogi, S.; Silverberg, J.I. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J. Am. Acad. Dermatol. 2019, 80, 1526–1532.e1527. [CrossRef]

4. Reed, B.; Blaiss, M.S. The burden of atopic dermatitis. Allergy Asthma Proc. 2018, 39, 406–410. [CrossRef]

5. Ali, F.; Vyas, J.; Finlay, A.Y. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life. Acta Derm. Venereol. 2020, 100, adv00161. [CrossRef]

6. Laughter, M.R.; Maymone, M.B.C.; Mashayekhi, S.; Arents, B.W.M.; Karimkhani, C.; Langan, S.M.; Dellavalle, R.P.; Flohr, C. The global burden of atopic dermatitis: Lessons from the Global Burden of Disease Study 1990–2017. Br. J. Dermatol. 2021, 184, 304–309. [CrossRef]

7. Birdi, G.; Cooke, R.; Knibb, R.C. Impact of atopic dermatitis on quality of life in adults: A systematic review and meta-analysis. Int. J. Dermatol. 2020, 59, e75–e91. [CrossRef] [PubMed]

8. Blome, C.; Radtke, M.A.; Eissing, L.; Augustin, M. Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit. Am. J. Clin. Dermatol. 2016, 17, 163–169. [CrossRef]

9. Halioua, B.; Beumont, M.G.; Lunel, F. Quality of life in dermatology. Int. J. Dermatol. 2000, 39, 801–806. [CrossRef]

10. Jeon, C.; Yan, D.; Nakamura, M.; Sekhon, S.; Bhutani, T.; Berger, T.; Liao, W. Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review. Dermatol. Ther. Heidelb. 2017, 7, 349–364. [CrossRef]

11. Tsai, T.F.; Rajagopalan, M.; Chu, C.Y.; Encarnacion, L.; Gerber, R.A.; Santos-Estrella, P.; Llamado, L.J.Q.; Tallman, A.M. Burden of atopic dermatitis in Asia. J. Dermatol. 2019, 46, 825–834. [CrossRef]

12. Lopez Carrera, Y.I.; Al Hammadi, A.; Huang, Y.H.; Llamado, L.J.; Mahgoub, E.; Tallman, A.M. Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review. Dermatol. Ther. Heidelb. 2019, 9, 685–705. [CrossRef] [PubMed]

13. Nutten, S. Atopic dermatitis: Global epidemiology and risk factors. Ann. Nutr. Metab. 2015, 66 (Suppl. 1), 8–16. [CrossRef] [PubMed]

14. Pedersen, C.J.; Uddin, M.J.; Saha, S.K.; Darmstadt, G.L. Prevalence of atopic dermatitis, asthma and rhinitis from infancy through adulthood in rural Bangladesh: A population-based, cross-sectional survey. BMJ Open 2020, 10, e042380. [CrossRef] [PubMed]

15. Pedersen, C.J.; Uddin, M.J.; Saha, S.K.; Darmstadt, G.L. Prevalence and psychosocial impact of atopic dermatitis in Bangladeshi children and families. PLoS ONE 2021, 16, e0249824. [CrossRef]

16. Basra, M.K.A.; Fenech, R.; Gatt, R.M.; Salek, M.S.; Finlay, A.Y. The Dermatology Life Quality Index 1994–2007: A comprehensive review of validation data and clinical results. Br. J. Dermatol. 2008, 159, 997–1035. [CrossRef]

17. Williams, H.C.; Burney, P.G.; Hay, R.J.; Archer, C.B.; Shipley, M.J.; Hunter, J.J.; Bingham, E.A.; Finlay, A.Y.; Pembroke, A.C.; Graham-Brown, R.A.; et al. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br. J. Dermatol. 1994, 131, 383–396. [CrossRef]

18. Hanifin, J.M.; Thurston, M.; Omoto, M.; Cherill, R.; Tofte, S.J.; Graeber, M. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp. Dermatol. 2001, 10, 11–18. [CrossRef]

19. Finlay, A.Y.; Khan, G.K. Dermatology Life Quality Index (DLQI)—A simple practical measure for routine clinical use. Clin. Exp. Dermatol. 1994, 19, 210–216. [CrossRef]

20. Hongbo, Y.; Thomas, C.L.; Harrison, M.A.; Salek, M.S.; Finlay, A.Y. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J. Investig. Dermatol. 2005, 125, 659–664. [CrossRef]

21. Vakharia, P.P.; Chopra, R.; Sacotte, R.; Patel, N.; Immaneni, S.; White, T.; Kantor, R.; Hsu, D.Y.; Silverberg, J.I. Validation of patient-reported global severity of atopic dermatitis in adults. Allergy 2018, 73, 451–458. [CrossRef]

22. Faul, F.; Erdfelder, E.; Buchner, A.; Lang, A.G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav. Res. Methods 2009, 41, 1149–1160. [CrossRef]

23. Majbauddin, A.; Otani, S.; Tsunekawa, A.; Haregeweyn, N.; Abeje, M.T.; Nigussie, Z.; Alam, I.; Qing, Q.; Masumoto, T.; Kurozawa, Y. The Influence of Income and Livelihood Diversification on Health-Related Quality of Life in Rural Ethiopia. Int. J. Environ. Res. Public Health 2020, 17, 2709. [CrossRef]

24. Holm, J.G.; Agner, T.; Clausen, M.L.; Thomsen, S.F. Quality of life and disease severity in patients with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 1760–1767. [CrossRef]

25. Sanchez-Perez, J.; Dauden-Tello, E.; Mora, A.M.; Lara Surinyac, N. Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: The PSEDA study. Actas Dermosifiliogr. 2013, 104, 44–52. [CrossRef]

26. Silverberg, J.I.; Gelfand, J.M.; Margolis, D.J.; Boguniewicz, M.; Fonacier, L.; Grayson, M.H.; Simpson, E.L.; Ong, P.Y.; Chiesa Fuxench, Z.C. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Ann. Allergy Asthma Immunol. 2018, 121, 340–347. [CrossRef]

27. Huang, J.; Choo, Y.J.; Smith, H.E.; Apfelbacher, C. Quality of life in atopic dermatitis in Asian countries: A systematic review. Arch. Dermatol. Res. 2021. [CrossRef]

28. Coghi, S.; Bortoletto, M.C.; Sampaio, S.A.; Andrade Junior, H.F.; Aoki, V. Quality of life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clin. Sao Paulo 2007, 62, 235–242. [CrossRef]

29. Maksimovic, N.; Jankovic, S.; Marinkovic, J.; Sekulovic, L.K.; Zivkovic, Z.; Spiric, V.T. Health-related quality of life in patients with atopic dermatitis. J. Dermatol. 2012, 39, 42–47. [CrossRef] [PubMed]

30. Holm, E.A.; Wulf, H.C.; Stegmann, H.; Jemec, G.B.E. Life quality assessment among patients with atopic eczema. Br. J. Dermatol. 2006, 154, 719–725. [CrossRef] [PubMed]

31. Hsieh, B.J.; Shen, D.; Hsu, C.J.; Chan, T.C.; Cho, Y.T.; Tang, C.H.; Chu, C.Y. The impact of atopic dermatitis on health-related quality of life in Taiwan. J. Formos. Med. Assoc. 2021, in press. [CrossRef] [PubMed]

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る